These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
614 related articles for article (PubMed ID: 29671956)
1. Atherosclerosis and autoimmunity: a growing relationship. Sanjadi M; Rezvanie Sichanie Z; Totonchi H; Karami J; Rezaei R; Aslani S Int J Rheum Dis; 2018 May; 21(5):908-921. PubMed ID: 29671956 [TBL] [Abstract][Full Text] [Related]
2. Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings. Zinger H; Sherer Y; Shoenfeld Y Clin Rev Allergy Immunol; 2009 Aug; 37(1):20-8. PubMed ID: 18991025 [TBL] [Abstract][Full Text] [Related]
3. Inflammation and atherosclerosis: what is on the horizon? Ruparelia N; Choudhury R Heart; 2020 Jan; 106(1):80-85. PubMed ID: 31843811 [No Abstract] [Full Text] [Related]
5. Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect. Fredman G; MacNamara KC Cardiovasc Res; 2021 Nov; 117(13):2563-2574. PubMed ID: 34609505 [TBL] [Abstract][Full Text] [Related]
6. Functional diversity of macrophages in vascular biology and disease. Park I; Kassiteridi C; Monaco C Vascul Pharmacol; 2017 Dec; 99():13-22. PubMed ID: 29074468 [TBL] [Abstract][Full Text] [Related]
7. Atherosclerosis and immunity: A perspective. Abdolmaleki F; Gheibi Hayat SM; Bianconi V; Johnston TP; Sahebkar A Trends Cardiovasc Med; 2019 Aug; 29(6):363-371. PubMed ID: 30292470 [TBL] [Abstract][Full Text] [Related]
8. Macrophages and dendritic cells: the usual suspects in atherogenesis. Kassiteridi C; Monaco C Curr Drug Targets; 2015; 16(4):373-82. PubMed ID: 25808566 [TBL] [Abstract][Full Text] [Related]
9. Atherosclerosis: Beyond the lipid storage hypothesis. The role of autoimmunity. Cinoku II; Mavragani CP; Moutsopoulos HM Eur J Clin Invest; 2020 Feb; 50(2):e13195. PubMed ID: 31868918 [TBL] [Abstract][Full Text] [Related]
11. Novel anti-inflammatory therapies for the treatment of atherosclerosis. Khan R; Spagnoli V; Tardif JC; L'Allier PL Atherosclerosis; 2015 Jun; 240(2):497-509. PubMed ID: 25917947 [TBL] [Abstract][Full Text] [Related]
12. The role of damage- and pathogen-associated molecular patterns in inflammation-mediated vulnerability of atherosclerotic plaques. Rai V; Agrawal DK Can J Physiol Pharmacol; 2017 Oct; 95(10):1245-1253. PubMed ID: 28746820 [TBL] [Abstract][Full Text] [Related]
13. Is preclinical autoimmunity benign?: The case of cardiovascular disease. Majka DS; Chang RW Rheum Dis Clin North Am; 2014 Nov; 40(4):659-68. PubMed ID: 25437283 [TBL] [Abstract][Full Text] [Related]
14. 2016 Jeffrey M. Hoeg Award Lecture. Rouwet E; Lutgens E Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1678-1688. PubMed ID: 29930003 [TBL] [Abstract][Full Text] [Related]
15. Inflammation and atherosclerosis. Hansson GK; Robertson AK; Söderberg-Nauclér C Annu Rev Pathol; 2006; 1():297-329. PubMed ID: 18039117 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in therapeutic targeting of inflammation in atherosclerosis. Hedin U; Matic LP J Vasc Surg; 2019 Mar; 69(3):944-951. PubMed ID: 30591299 [TBL] [Abstract][Full Text] [Related]
17. Inflammation during the life cycle of the atherosclerotic plaque. Libby P Cardiovasc Res; 2021 Nov; 117(13):2525-2536. PubMed ID: 34550337 [TBL] [Abstract][Full Text] [Related]
18. IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles. Taleb S; Tedgui A; Mallat Z Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):258-64. PubMed ID: 25234818 [TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for the prevention of atherosclerotic cardiovascular disease: Promise and possibilities. Khambhati J; Engels M; Allard-Ratick M; Sandesara PB; Quyyumi AA; Sperling L Atherosclerosis; 2018 Sep; 276():1-9. PubMed ID: 30006321 [TBL] [Abstract][Full Text] [Related]